Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Behcet SyndromeBehcet DiseaseMucocutaneous Ulceration
Interventions
BIOLOGICAL

Veldona,

Very low dose oral natural human interferon alpha lozenges

Trial Locations (4)

Unknown

Gulhane Military Medical School, Ankara

Osmangazi University Medical School, Dept of Rheumatology, Eskişehir

Istanbul University Cerrahpasa Medical School Department of Internal Medicine, Istanbul

Istanbul University Istanbul Medical School, Istanbul

Sponsors
All Listed Sponsors
collaborator

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

INDUSTRY

lead

Nobel Pharmaceuticals

INDUSTRY